AAAAAA
Results:
1-22
|
Results: 22
Authors:
TOKUNAGA J
KOBAYASHI M
KITAGAWA A
NAKAMURA C
ARIMORI K
NAKANO M
Citation: J. Tokunaga et al., PROTECTIVE EFFECTS OF BETAMIPRON ON RENAL TOXICITY DURING REPEATED CISPLATIN ADMINISTRATION IN RATS AND PROTECTIVE MECHANISM, Renal failure, 20(1), 1998, pp. 27-38
Authors:
ARIMORI K
NAKANO M
Citation: K. Arimori et M. Nakano, DRUG EXSORPTION FROM BLOOD INTO THE GASTROINTESTINAL-TRACT, Pharmaceutical research, 15(3), 1998, pp. 371-376
Authors:
ARIMORI K
MIYAMOTO S
FUKUDA K
NAKAMURA C
NAKANO M
Citation: K. Arimori et al., CHARACTERISTIC DIFFERENCE IN GASTROINTESTINAL EXCRETION OF CLARITHROMYCIN AND ROXITHROMYCIN, Biopharmaceutics & drug disposition, 19(7), 1998, pp. 433-438
Authors:
SCHUETZ EG
YASUDA K
ARIMORI K
SCHUETZ JD
Citation: Eg. Schuetz et al., HUMAN MDR1 AND MOUSE MDR1A P-GLYCOPROTEIN ALTER THE CELLULAR RETENTION AND DISPOSITION OF ERYTHROMYCIN, BUT NOT OF RETINOIC ACID OR BENZO(A)PYRENE, Archives of biochemistry and biophysics, 350(2), 1998, pp. 340-347
Authors:
MORIYAMA Y
ARIMORI K
NAKANO M
Citation: Y. Moriyama et al., ABSORPTION CHARACTERISTICS OF AZASETRON FROM RECTAL AND ORAL ROUTES IN RABBITS, Biological & pharmaceutical bulletin, 20(6), 1997, pp. 701-703
Authors:
TOKUNAGA J
KOBAYASHI M
KITAGAWA A
NAKAMURA C
ARIMORI K
NAKANO M
Citation: J. Tokunaga et al., EFFECTS OF BETAMIPRON ON CISPLATIN NEPHROTOXICITY AND ITS PHARMACOKINETICS IN RATS, Biological & pharmaceutical bulletin, 20(4), 1997, pp. 386-391
Authors:
TSURUTA S
NAKAMURA K
ARIMORI K
NAKANO M
Citation: S. Tsuruta et al., EFFECTS OF ERYTHROMYCIN, CLARITHROMYCIN AND ROKITAMYCIN ON NIFEDIPINEMETABOLISM IN RATS, Biological & pharmaceutical bulletin, 20(4), 1997, pp. 411-416
Authors:
TOKUNAGA J
KOBAYASHI M
NAKAMURA C
KITAGAWA A
ARIMORI K
NAKANO M
Citation: J. Tokunaga et al., BETAMIPRON REDUCES CISPLATIN NEPHROTOXICITY IN RODENTS WITHOUT MODIFYING ITS ANTILEUKEMIC ACTIVITY IN MICE, Renal failure, 19(3), 1997, pp. 425-438
Authors:
KATSUKI H
NAKAMURA C
ARIMORI K
FUJIYAMA S
NAKANO M
Citation: H. Katsuki et al., GENETIC-POLYMORPHISM OF CYP2C19 AND LANSOPRAZOLE PHARMACOKINETICS IN JAPANESE SUBJECTS, European Journal of Clinical Pharmacology, 52(5), 1997, pp. 391-396
Authors:
THOTTASSERY JV
ZAMBETTI GP
ARIMORI K
SCHUETZ EG
SCHUETZ JD
Citation: Jv. Thottassery et al., P53-DEPENDENT REGULATION OF MDR1 GENE-EXPRESSION CAUSES SELECTIVE RESISTANCE TO CHEMOTHERAPEUTIC-AGENTS, Proceedings of the National Academy of Sciences of the United Statesof America, 94(20), 1997, pp. 11037-11042
Authors:
TSURUTA S
NAKAMURA K
ARIMORI K
NAKANO M
Citation: S. Tsuruta et al., INHIBITION OF NIFEDIPINE METABOLISM IN DOGS BY ERYTHROMYCIN - DIFFERENCE BETWEEN THE GUT WALL AND THE LIVER, Journal of Pharmacy and Pharmacology, 49(12), 1997, pp. 1205-1210
Authors:
TOKUNAGA J
KOBAYASHI M
KITAGAWA A
NAKAMURA C
ARIMORI K
NAKANO M
Citation: J. Tokunaga et al., PROTECTIVE EFFECTS OF N-BENZOYL AMINO-ACIDS ON CISPLATIN NEPHROTOXICITY IN RATS, Biological & pharmaceutical bulletin, 19(11), 1996, pp. 1451-1456
Authors:
TOKUNAGA J
KOBAYASHI M
NAKAMURA C
KITAGAWA A
ARIMORI K
NAKANO M
Citation: J. Tokunaga et al., PROTECTIVE EFFECT OF N-BENZOYL-BETA-ALANINE AGAINST CISPLATIN NEPHROTOXICITY IN RATS, Renal failure, 18(2), 1996, pp. 225-240
Authors:
KATSUKI H
YAGI H
ARIMORI K
NAKAMURA C
NAKANO M
KATAFUCHI S
FUJIOKA Y
FUJIYAMA S
Citation: H. Katsuki et al., DETERMINATION OF R(-LANSOPRAZOLE AND S(-)-LANSOPRAZOLE USING CHIRAL STATIONARY-PHASE LIQUID-CHROMATOGRAPHY AND THEIR ENANTIOSELECTIVE PHARMACOKINETICS IN HUMANS()), Pharmaceutical research, 13(4), 1996, pp. 611-615
Authors:
MATSUO M
ARIMORI K
NAKAMURA C
NAKANO M
Citation: M. Matsuo et al., DELAYED-RELEASE TABLETS USING HYDROXYETHYLCELLULOSE AS A GEL-FORMING MATRIX, International journal of pharmaceutics, 138(2), 1996, pp. 225-235
Authors:
TOMIMARU A
ARIMORI K
INOTSUME N
NAKANO M
Citation: A. Tomimaru et al., EFFECT OF ACTIVATED-CHARCOAL AND ATROPINE ON ABSORPTION AND OR EXSORPTION OF ORGANOPHOSPHORUS COMPOUNDS IN RATS/, Journal of Pharmacy and Pharmacology, 48(4), 1996, pp. 351-356
Authors:
YONEKURA S
KAWADA H
WATANABE S
SATOH H
OGAWA Y
MASUMOTO A
FUKUDA R
UMEDA Y
ARIMORI K
KUBOTA N
NAGAO T
Citation: S. Yonekura et al., TREATMENT WITH RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR AFTER CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA, Current therapeutic research, 57(4), 1996, pp. 268-277
Authors:
ICHIKAWA Y
ARIMORI K
YOSHIDA M
HORIKI T
HOSHINA Y
MORITA K
UCHIYAMA M
SHIMIZU H
MORIUCHI J
Citation: Y. Ichikawa et al., ABNORMAL EXPRESSION OF APOPTOSIS-RELATED ANTIGENS, FAS AND BCL-2, ON CIRCULATING T-LYMPHOCYTE SUBSETS IN PRIMARY SJOGRENS-SYNDROME, Clinical and experimental rheumatology, 13(3), 1995, pp. 307-313
Authors:
MATSUO M
NAKAMURA C
ARIMORI K
NAKANO M
Citation: M. Matsuo et al., EVALUATION OF HYDROXYETHYLCELLULOSE AS A HYDROPHILIC SWELLABLE MATERIAL FOR DELAYED-RELEASE TABLETS, Chemical and Pharmaceutical Bulletin, 43(2), 1995, pp. 311-314
Authors:
YOSHIMURA S
SUEMIZU H
TANIGUCHI Y
ARIMORI K
KAWABE N
MORIUCHI T
Citation: S. Yoshimura et al., THE HUMAN PLASMA GLUTATHIONE PEROXIDASE-ENCODING GENE - ORGANIZATION,SEQUENCE AND LOCALIZATION TO CHROMOSOME 5Q32, Gene, 145(2), 1994, pp. 293-297
Authors:
ARIMORI S
NOZAKI H
MORITA K
ARIMORI K
Citation: S. Arimori et al., CASE-REPORT - THE EFFECT OF A CHINESE HERBAL MEDICINE, BG-104 IN 2 HIV-POSITIVE HEMOPHILIACS, Biotherapy, 7(1), 1993, pp. 55-57
Authors:
ARIMORI K
DESHIMARU M
FURUKAWA E
NAKANO M
Citation: K. Arimori et al., ADSORPTION OF MEXILETINE ONTO ACTIVATED-CHARCOAL IN MACROGOL-ELECTROLYTE SOLUTION, Chemical and Pharmaceutical Bulletin, 41(4), 1993, pp. 766-768
Risultati:
1-22
|